2024年2月9日 · Data will be presented from an evaluation of fetal and neonatal drug exposure following nipocalimab treatment in pregnant individuals at risk of EOS HDFN during a poster …

Background: The spectrum of haemolytic disease of the foetus and newborn (HDFN) has changed over last few decades. With the implementation of Rh D immunoprophylaxis, HDFN …

2021年10月13日 · Mur are clinically significant causes of haemolytic disease of the foetus and newborn (HDFN), although not many cases have been reported in mainland China. Methods: …

2021年2月19日 · Hemolytic Disease of the Fetus and Newborn (HDFN) occurs when maternal IgG antibodies coat fetal red blood cells, causing their destruction both before and after birth. …

2023年10月21日 · Nipocalimab (Janssen) may be for the antenatal and postnatal management of fetal anemia in pregnancies at high risk for early-onset severe hemolytic disease of the fetus …

2025年2月7日 · In a recent study, researchers surveyed experts in fetal medicine and hematology to develop a consensus-based set of recommendations for managing hemolytic disease of the …

SAN DIEGO, CA, (December 9, 2024) – Johnson & Johnson (NYSE: JNJ) announced today findings from several online abstracts and posters on patients living with warm autoimmune …

2024年1月23日 · HDFN occurs when antibodies cross the placenta into the fetus’ circulation and destroys the fetus’ RBCs which can lead to serious – and potentially fatal – consequences for …

2018年7月10日 · This document discusses haemolytic disease of the fetus and newborn (HDFN), specifically Rh disease. It provides details on the pathophysiology, classification, antenatal …

Anti-K is an IgG antibody implicated in acute and delayed hemolytic transfusion reactions, as well as severe hemolytic disease of the fetus and newborn (HDFN) due to destruction of fetal …